Merck & Co

Experts Discuss Importance of Cancer Screenings and Early Detection

In this Teal Talks episode, TV host and cancer survivor Samantha Harris leads the conversation about the advances in cancer screenings and early prevention with three renowned cancer specialists

You may know Samantha Harris from hosting eight seasons of Dancing with the Stars and her many years on Entertainment Tonight, but she’s also a cancer survivor — or “cancer thriver,” as she prefers to be called.

At age 40, Harris was diagnosed with stage II invasive breast cancer and underwent a double mastectomy. Since her diagnosis, the Emmy-winning TV personality has become a fierce advocate for living a healthier life to help prevent chronic diseases like cancer.

'We Are Encouraged To Be Who We Are': An LGBTQ+ Colleague Shares His Story

Lutz Staacke talks about finding a company that appreciates him for who he is

As a university student in Germany, Lutz Staacke studied special education and planned to become a teacher. But before he began his classroom training, he was warned not to be open about his sexuality.

Growing up in a small, conservative town, Staacke had plenty of experience hiding his identity as a gay person, but he was tired of hiding. Instead, he decided to pursue a different career.

“I said to myself, I have to do something different. I just want to be who I am,” said Staacke.

Merck Joins Novartis-Led Collaboration To Increase Diversity in Clinical Trials

New collaboration expands our clinical trials efforts to four Historically Black Medical School clinical trial Centers of Excellence

Increasing diversity in clinical trials plays a crucial role in helping to understand how a broad range of human bodies may respond to drugs or other treatments. That’s why we’re committed to enrolling a diverse body of participants in our clinical trials around the globe.

How We're Supporting the Advancement of Women of Color at Our Company

We joined forces with Paradigm for Parity to help build skills and capabilities needed for senior leadership roles

The path to C-suite or executive level positions requires experience with managing a company’s profit and loss, also referred to as P&L. However, many women, specifically women of color, don’t get the opportunity to take on this responsibility — potentially limiting their ability to rise through the ranks within a company.

WEConnect International Named Merck a 2022 Platinum Top Global Supplier, Diversity & Inclusion Champion

Multimedia with summary

We are thrilled to announce that WEConnect International has named us a 2022 Platinum Top Global Supplier, Diversity & Inclusion Champion! The Platinum level of recognition denotes the highest level of dedication to inclusive spend, policies and procedures:

STEM Mentorship Program Helps Underrepresented Students Shine


Diversity and inclusion have long been recognized as key attributes of high-performing teams in the pharmaceutical and biotech industries. Unfortunately, ethnically diverse groups are underrepresented in the STEM (sciences, technology, engineering, and math) fields.

It’s essential to our industry and society that we do our part to nurture tomorrow’s rising diverse STEM experts. So, two of our discovery scientists decided to take action.

Celebrating Our Asian American and Pacific Islander Colleagues

During Asian American and Pacific Islander (AAPI) Heritage Month and beyond, we’re committed to supporting and saluting our AAPI colleagues and the important work they do

At Merck, embracing diversity is key to cultivating an inclusive environment where everyone can contribute their most innovative ideas. During Asian American and Pacific Islander (AAPI) Heritage month and beyond, we celebrate and take inspiration from our global workforce while embracing and encouraging allyship.

Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities

Press Release

KENILWORTH, N.J., January 10, 2022 /3BLMedia/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world where no woman has to die giving life.

Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort

We can’t do it alone. That’s why we’re saying a huge thank you.

Taking on COVID-19 isn’t just a team effort — it’s also a global one. Here at Merck, we’re grateful to all the people who have worked hard to keep us safe, along with everyone around the world helping to combat the pandemic.

That’s why we’re saying thank you!

Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

The Companies Are Committed To Providing Timely Access to Molnupiravir Through Comprehensive Supply and Access Approach

KENILWORTH, N.J. & MIAMI, December 28, 2021, /3BLMedia/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).


Subscribe to Merck & Co